Literature DB >> 33527646

New effective treatment options reinforce disease awareness: the case of transthyretin cardiac amyloidosis.

Stefano Perlini1,2, Roberta Mussinelli2, Francesco Salinaro1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33527646     DOI： 10.1002/ejhf.2111

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  1 in total

Review 1.  Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter Future.

Authors:  Laura Obici; Roberta Mussinelli
Journal:  Neurotherapeutics       Date:  2021-11-30       Impact factor: 6.088
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.